卵巢浆液性癌，行与未行腹膜后淋巴结切除术患者的5年生存率分别为61%、3 1% （P<0 0 1）。
Among patients with serous adenocarcinoma, 5-year survival was 61% and 31% for patients who did and did not undergo lymphadenectomy, respectively(P<0.01).
目的探讨腹膜后淋巴结切除术在初治及复发卵巢恶性生殖细胞肿瘤（OGCT）患者中对肿瘤复发及患者生存的影响。
Objective To evaluate the impact of lymphadenectomy on the relapse and survival of malignant ovarian germ cell tumor(OGCT).
结果多因素分析显示，年龄、临床分期、残留灶、腹膜后淋巴结切除术及术后化学药物治疗（化疗） ，是影响预后的重要因素。
Results Multivariate analysis showed that the age, stage, residual tumor, retroperitoneal lymphadenectomy and the number of courses of chemotherapy were the most important prognostic factors.
结果多因素分析显示，年龄、临床分期、残留灶、腹膜后淋巴结切除术及术后化学药物治疗（化疗） ，是影响预后的重要因素。
Results Multivariate analysis showed that the age, stage, residual tumor, retroperitoneal lymphadenectomy and the number of courses of chemotherapy were the most important prognostic factors.
应用推荐